Simplex Trading’s OnKure Therapeutics OKUR Stock Holding History

Simplex Trading’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,280	Closed	-$68K	–	10111
2023 Q4	$68K	Buy	4,280 +4,040	+1,683%	+$252K	﹤0.01%	5785
2023 Q3	$18K	Buy	+240	New	+$16.3K	﹤0.01%	6732

Other funds holding OKUR

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Simplex Trading's OKUR Position: Q4 2024 in Review

Simplex Trading sold out of OnKure Therapeutics (OKUR) in Q4 2024, closing a stake of 10 shares.

Simplex Trading first reported a position in OKUR in Q3 2024 and held it in 1 quarter. The position peaked at $0 in Q3 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q4 2024.

Simplex Trading reported no remaining OnKure Therapeutics position as of Q4 2024 after selling out during the quarter.
Simplex Trading sold 10 OnKure Therapeutics shares in Q4 2024.
Simplex Trading first reported a position in OnKure Therapeutics in Q3 2024 and held it in 1 quarter.
Simplex Trading's OnKure Therapeutics position peaked at $0 in Q3 2024.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.